Impact of the use of immunoglobulin palivizumab in the State of São Paulo: a cohort study
ABSTRACT Introduction: the use of palivizumab as prophylaxis of the respiratory syncytial virus is not a consensus. In Brazil, it is a public health program, but other countries do not consider it cost-effective. Objective: to identify the rate of hospitalization in Intensive Care Unit for respirato...
Saved in:
Main Authors: | Ivana Regina Gonçalves (Author), Marli Teresinha Cassamassimo Duarte (Author), Helio Rubens de Carvalho Nunes (Author), Rubia de Aguiar Alencar (Author), Cristina Maria Garcia de Lima Parada (Author) |
---|---|
Format: | Book |
Published: |
Universidade de São Paulo,
2017-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Avaliação do programa de uso da imunoglobulina palivizumabe no Estado de São Paulo, Brasil
by: Ivana Regina Gonçalves, et al.
Published: (2018) -
Vulnerabilidade de idosos a infecções sexualmente transmissíveis
by: Juliane Andrade, et al.
Published: (2017) -
Evaluation of respiratory complications in a cohort of preterm infants who did not receive palivizumab monoclonal antibodies
by: Poliana Castro de Resende Bonati, et al.
Published: (2022) -
PALIVIZUMAB: NEW OPPORTUNITIES FOR THE ASTHMA PREVENTION?
by: E.A. Vishneva, et al.
Published: (2011) -
PALIVIZUMAB: NEW OPPORTUNITIES FOR THE ASTHMA PREVENTION?
by: E.A. Vishneva, et al.
Published: (2011)